시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 성병(STD) 검사 시장 보고서(2025년)
Sexually Transmitted Diseases (STD) Testing Global Market Report 2025
상품코드 : 1769746
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,312,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,124,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,936,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

성병(STD) 검사 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 이러한 예상되는 확장은 전 세계적으로 성병 발생률이 증가하고, 성 건강 문제에 대한 인식이 높아지며, 증상이 없는 감염률이 높고, 성적으로 활동하는 청소년과 청소년의 수가 증가하고, 위험한 성 행동이 급증한 데 기인할 수 있습니다.

HIV의 유병률 증가는 향후 수년간 성병(STD) 검사 시장의 성장을 가속할 것으로 예측됩니다. HIV 감염자 증가는 무방비한 섹스와 같은 위험한 행동을 취하는 사람 증가와 검사를 받는 사람의 감소, 특히 젊은이의 감소로 이어지고 있습니다. 의료 관계자의 의식이 높아져 감염을 조기에 발견하고 추가 감염 확대를 막기 위해 종합적인 검사를 받는 사람이 늘고 있습니다. 2023년에 새롭게 HIV에 감염된 사람은 약 130만명으로, 37만명 미만이라고 하는 2025년의 목표치의 약 3배가 되고 있습니다. 따라서, HIV의 유병률 증가는 STD 검사 수요를 높일 것으로 예측됩니다.

성병(STD) 검사 시장의 주요 기업은 접근성과 정확성을 향상시키기 위해 매독 검사 키트와 같은 고급 솔루션 개발에 주력하고 있습니다. 다른 체액을 이용하여 매독의 원인균인 트레포네마 파리덤균을 검출하여 시기 적절한 진단과 치료를 가능하게 합니다. iHealth Labs Inc.는 HIV와 매독 검사를 위한 CheckMeSafe 홈 컬렉션 키트를 출시했습니다. 이송, 최단 2일에 기밀성 높은 신뢰할 수 있는 결과를 받을 수 있습니다. 키트의 감도는 HIV에서 99.9%, 매독으로 99.5%에 도달하고 높은 정확도를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Sexually transmitted disease (STD) testing refers to the medical procedure used to detect infections primarily transmitted through sexual contact. It is essential for early diagnosis, which helps prevent complications and controls the spread of infections through timely treatment and counseling. Regular screening is often advised for sexually active individuals since many infections may not present immediate symptoms but can still be contagious.

The main components of sexually transmitted disease (STD) testing include instruments and services, consumables, and software. Instruments and services comprise the diagnostic devices and support activities utilized in clinical environments for conducting medical tests. These employ both immunoassay and molecular diagnostic technologies and can analyze blood, urine, swabs, semen, and other sample types. This testing is applied for various diseases such as chlamydia, gonorrhea, syphilis, HIV/AIDS, and herpes simplex virus (HSV), serving a range of end users including individuals, healthcare providers, health insurers, government health agencies, NGOs, and community health organizations.

The sexually transmitted diseases (STD) testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted diseases (STD) testing market statistics, including sexually transmitted diseases (STD) testing industry global market size, regional shares, competitors with a sexually transmitted diseases (STD) testing market share, detailed sexually transmitted diseases (STD) testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted diseases (STD) testing industry. This sexually transmitted diseases (STD) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted diseases (STD) testing market size has grown strongly in recent years. It will grow from $8.08 billion in 2024 to $8.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. Growth during the past years has been driven by increasing urbanization and population density, a growing aging population maintaining active sexual lifestyles, government efforts to promote STD screening, the integration of STD testing into routine health examinations, and greater funding for public health initiatives.

The sexually transmitted diseases (STD) testing market size is expected to see strong growth in the next few years. It will grow to $12.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. This anticipated expansion can be credited to the rising global incidence of STDs, enhanced awareness of sexual health issues, the high rate of infections without symptoms, the increasing number of sexually active adolescents and young adults, and a surge in risky sexual behaviors. Key trends forecasted include the rise of rapid and point-of-care testing, the emergence of home-based STD testing kits, progress in molecular diagnostic methods, greater automation and AI integration in diagnostic labs, and improved accuracy and reliability of new testing kits.

The increasing prevalence of HIV is expected to drive the growth of the sexually transmitted diseases (STD) testing market in the upcoming years. HIV attacks and destroys vital white blood cells, weakening the immune system and making the body more susceptible to infections and diseases. The rise in HIV cases is linked to a decline in awareness and prevention efforts, leading to more individuals engaging in risky behaviors such as unprotected sex and fewer people, especially youth, getting tested. This increase in HIV cases has raised public and healthcare awareness, encouraging more people to seek comprehensive testing to detect infections early and prevent further spread. For example, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2024, approximately 1.3 million people were newly infected with HIV in 2023, nearly three times higher than the 2025 target of fewer than 370,000 cases. Therefore, the growing prevalence of HIV is expected to enhance the demand for STD testing.

Key players in the sexually transmitted diseases (STD) testing market are focusing on the development of advanced solutions, such as syphilis testing kits, to improve accessibility and accuracy. These kits detect the Treponema pallidum bacteria, which causes syphilis, using blood or other bodily fluids, enabling timely diagnosis and treatment. For instance, in August 2023, iHealth Labs Inc., a US medical device company, launched the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples at home for HIV (I, II, P24 antigen) and syphilis testing. Users can send their samples to the lab with a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers high accuracy, with sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples are tested in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with stringent federal and state quality standards through regular inspections.

In December 2023, imaware, a US-based company providing at-home health testing kits, acquired binx health's at-home consumer testing division. This acquisition will help imaware strengthen its position in the growing home-health testing market and expand its enterprise client base. Meanwhile, binx health will continue to develop and grow its point-of-care molecular diagnostics division, which was not part of the acquisition. Binx health is a US-based provider of sexually transmitted disease (STD) testing solutions.

Major players in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., and AEHEALTH LIMITED.

North America was the largest region in the sexually transmitted diseases (STD) testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted diseases (STD) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted diseases (STD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted diseases (STD) testing market consists of revenues earned by entities by providing services such as confidential testing, walk-in clinic testing, online test ordering, telehealth consultations, and partner notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted diseases (STD) testing market also includes sales of at-home test kits, multi-infection panel kits, blood collection devices, biohazard specimen bags, and portable sample storage containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted diseases (std) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sexually transmitted diseases (std) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sexually transmitted diseases (std) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Sexually Transmitted Diseases (STD) Testing Market Characteristics

3. Sexually Transmitted Diseases (STD) Testing Market Trends And Strategies

4. Sexually Transmitted Diseases (STD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Diseases (STD) Testing Growth Analysis And Strategic Analysis Framework

6. Sexually Transmitted Diseases (STD) Testing Market Segmentation

7. Sexually Transmitted Diseases (STD) Testing Market Regional And Country Analysis

8. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market

9. China Sexually Transmitted Diseases (STD) Testing Market

10. India Sexually Transmitted Diseases (STD) Testing Market

11. Japan Sexually Transmitted Diseases (STD) Testing Market

12. Australia Sexually Transmitted Diseases (STD) Testing Market

13. Indonesia Sexually Transmitted Diseases (STD) Testing Market

14. South Korea Sexually Transmitted Diseases (STD) Testing Market

15. Western Europe Sexually Transmitted Diseases (STD) Testing Market

16. UK Sexually Transmitted Diseases (STD) Testing Market

17. Germany Sexually Transmitted Diseases (STD) Testing Market

18. France Sexually Transmitted Diseases (STD) Testing Market

19. Italy Sexually Transmitted Diseases (STD) Testing Market

20. Spain Sexually Transmitted Diseases (STD) Testing Market

21. Eastern Europe Sexually Transmitted Diseases (STD) Testing Market

22. Russia Sexually Transmitted Diseases (STD) Testing Market

23. North America Sexually Transmitted Diseases (STD) Testing Market

24. USA Sexually Transmitted Diseases (STD) Testing Market

25. Canada Sexually Transmitted Diseases (STD) Testing Market

26. South America Sexually Transmitted Diseases (STD) Testing Market

27. Brazil Sexually Transmitted Diseases (STD) Testing Market

28. Middle East Sexually Transmitted Diseases (STD) Testing Market

29. Africa Sexually Transmitted Diseases (STD) Testing Market

30. Sexually Transmitted Diseases (STD) Testing Market Competitive Landscape And Company Profiles

31. Sexually Transmitted Diseases (STD) Testing Market Other Major And Innovative Companies

32. Global Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Diseases (STD) Testing Market

34. Recent Developments In The Sexually Transmitted Diseases (STD) Testing Market

35. Sexually Transmitted Diseases (STD) Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기